AGP Wire

AGP

The Business Research Company says the Ajovy market is set to expand through 2035 as migraine diagnoses rise, preventive treatment gains ground and biologic therapies become more accepted.

AGP

The Business Research Company says Aimovig’s global market is set to expand through 2035, driven by rising migraine diagnoses, broader insurance coverage, and growing use of preventive biologics.

AGP

The Business Research Company says the global Albuked market has long-term growth potential through 2035, driven by rising liver disease cases, ICU demand and interest in safer non-plasma alternatives.

AGP

The Business Research Company says the Afstyla market is gaining traction as hemophilia A diagnoses rise and more patients move toward recombinant factor VIII therapies.

AGP

Worldreader says nearly 2,000 families in more than 40 countries read together during its first All Families Reading Challenge in September, topping the 10-book goal by a wide margin.

AGP

The Business Research Company projects the global Addison’s disease market will grow from $2.46 billion in 2026 to $3.53 billion by 2030. The report points to rising autoimmune disease rates, broader diagnostic access and newer treatment…

AGP

Huaxin Power Systems International Co., Ltd. is presenting its Cummins-powered generator lineup at Middle East Energy in Dubai, targeting demand from contractors, data centers, developers and industrial buyers across the Middle East and beyond….

AGP

The Business Research Company says the global addiction rehab facilities market is growing on rising substance use disorder rates, better insurance coverage and expanding treatment options.

AGP

The Business Research Company says the Afrezza market is set for stronger growth through 2035, driven by rising diabetes cases, higher healthcare spending and broader acceptance of inhaled insulin.

AGP

The Business Research Company says the global market for Adstiladrin, a gene therapy for high-risk non-muscle-invasive bladder cancer, is being shaped by rising bladder cancer cases, higher healthcare spending, and broader adoption of precision…

AGP

The Business Research Company says the global Afrezza market is set for stronger growth through 2035 as diabetes cases rise, healthcare spending increases and inhaled insulin gains wider acceptance.

AGP

The adeno-associated viral vectors market is projected to climb from $3.17 billion in 2025 to $6.65 billion by 2030 as gene therapy activity expands worldwide.

AGP

Moda Por Una Causa announced its sixth edition for Nov. 5 in San Salvador’s Historic Center, bringing together designers, models and creative partners from across Latin America and beyond.

AGP

The Business Research Company says the global Afluria Quadrivalent vaccine market is being shaped by rising flu incidence, broader pediatric immunization and higher healthcare spending.

AGP

Rick Rolland was named Man of the Year at the 2026 PreSEAS a la Excelencia en Seguridad in Mexico City on Oct. 3, recognizing more than two decades of work building Rolland Solutions’ presence in Mexico.

AGP

Rolland Solutions said Rick Rolland was named Man of the Year at the 2026 PreSEAS awards in Mexico City on Oct. 3, recognizing more than 20 years of work building the company’s security business in Mexico.

AGP

KinPath Surrogacy says it has helped more than 300 intended parents and 300 surrogates over 13 years, and is expanding its flagship program to Mérida, Mexico.

AGP

The acute respiratory distress syndrome market is forecast to grow from $1.41 billion in 2025 to $2.42 billion by 2030, driven by rising respiratory illness, ICU expansion and advances in ventilation and ECMO. North America held the largest market…

AGP

The global adipose tissue derived stem cell market is forecast to grow from $1.35 billion in 2026 to $2.14 billion by 2030, driven by regenerative medicine, cell-therapy commercialization and broader clinical use. North America led the market in…

AGP

The Business Research Company says the Afluria vaccine market is set to expand through 2035, driven by seasonal flu outbreaks, broader vaccination coverage and a growing older population.